Juno shares surge on news of $1 billion payment from Celgene

Juno agrees to a 10-year collaboration with Celgene on cancer and autoimmune disease treatments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.